Skip to content
Recall Observatory FDA recall evidence

Drug product

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.

D-1513-2014

July 14, 2014

Class III

Product summary

Firm
Wockhardt Usa Inc.
Event
Event 68813
Status
Terminated
Classification
Class III
Quantity
840 bottles
Official record key
drug-enforcement:D-1513-2014

Official wording

Reason: Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.

Code information: Lot #: DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification